News Alert: BriaCell (Nasdaq: BCTX) (TSX: BCT) Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer -21 of 29 terminal patients treated since 2022 are alive https://finance.yahoo.com/news/briacell-reports-benchmark-beating-patient-110000318.html